版本:
中国

Pfizer Inc (PFE.N)

PFE.N ( 纽约证券交易所 )

34.34USD
23 Aug 2019
涨跌 (%)

$-0.74 (-2.11%)
收盘
$35.08
开盘
$35.25
当日最高
$35.35
当日最低
$34.17
成交量
9,364,538
平均成交量
6,706,910
52 周最高
$46.46
52 周最低
$33.97

概况

辉瑞公司是全球研究型生物制药公司。该公司从事医疗产品的探索、开发及生产业务。该公司通过辉瑞创新卫生部门及辉瑞基本卫生部门运营。其生物制药产品包括“Lipitor”、“Sutent”及“Premarin”系列产品。其生物技术产品包括“BeneFIX”、“ReFacto”及 “Xyntha”等。该公司通过Pfizer... (更多)

概况

Beta: 0.61
市值(百万): $230,459.09
已发行股本(百万): 5,559.93
股息: 0.36
股息收益率 (%): 3.47

财务指标

  PFE.N Industry Sector
P/E (TTM): 22.95 29.73 33.85
EPS (TTM): 1.81 -- --
ROI: 8.15 13.04 12.69
ROE: 16.55 14.12 17.13

UPDATE 2-GSK's long acting HIV injection gets boost from study

* GSK up against competition from Gilead's 3-drug combo (Releads, adds background on rivalry with Gilead) 全文
08/22 18:19

GSK new HIV two-drug injection meets main goal in late-stage study

Aug 22 British drugmaker GlaxoSmithKline Plc said on Thursday its long-lasting two-drug regimen to treat HIV met the main goal of a late-stage study. 全文
08/22 14:40

Pfizer invests $500 million in expanding gene therapy facility

Aug 21 Pfizer Inc is investing $500 million to expand a manufacturing facility in Sanford, North Carolina, that plays a central role in its efforts to become a major player in gene therapy, the company said on Wednesday. 全文
08/21 22:01

UPDATE 3-Elanco to become No.2 in animal health with $7.6 bln Bayer deal

* Elanco gains strength in e-commerce, tick and flea control (Adds shares, Roundup litigation, Elanco rights issue) 全文
08/20 23:01

Teva to launch generic version of EpiPen for young children

Aug 20 Teva Pharmaceutical Industries Ltd said on Tuesday its generic version of Mylan's EpiPen for young children will be available in most retail pharmacies at a price of $300 for a 2-pack. 全文
08/20 20:23

Elanco to buy Bayer's animal health unit for $7.6 billion

Aug 20 Elanco Animal Health Inc said on Tuesday it would buy Bayer AG's animal health unit in a cash and stock deal valued at $7.6 billion, a move that would create the second largest animal health business and expand Elanco's reach in the pet e-commerce space. 全文
08/20 17:45

UPDATE 2-U.S. FDA declines to approve Sarepta's second Duchenne treatment

Aug 19 Sarepta Therapeutics Inc said on Monday the U.S. Food and Drug Administration declined to approve its newest treatment for Duchenne muscular dystrophy (DMD), citing safety concerns including the risk of infection and kidney toxicity. 全文
08/20 08:40

UPDATE 2-AbbVie prices new rheumatoid arthritis drug at $59,000/yr

Aug 16 AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on Friday, a big boost for the drugmaker struggling with rising competition for Humira, its blockbuster therapy for the same condition. 全文
08/17 02:19

背景资料:台湾主要外币债券发行情况一览

路透台北8月16日 - 台湾自2014年年中起陆续松绑国际债券发行规定,令美元债券等外币债发行热度增温 。 根据柜台买卖中心计算,2019年台湾国际板债券除人民币债外的其他外币债共发行173.5亿美元,另有49. 2亿南非兰特、1.2亿澳元。 2018年则发行306.11亿美元,另有5.75亿南非兰特。 各档外币债次级交易代码请参阅 ,人民币债券发行一览请见 以下为路透整理的2017年以来在台湾发行的主要外币债券(不含人民币)一览表: 日期 发债主体 发债额 利率(IRR) 年期 2019年 *2019.08 Malayan Banking Berhad 8.50亿美元 2.9684% 5 *2019.08 JPMorgan Chase 0.90亿美元 0%(4.30%) 40 全文
08/16 15:26

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development deals with partners, the company's chief executive told Reuters. 全文
08/14 13:45

竞争者

  现值 涨跌额
Johnson & Johnson (JNJ.N) $127.73 -3.54
Novartis AG (NOVN.S) CHF87.34 -0.42
Merck & Co., Inc. (MRK.N) $84.94 -1.78
Roche Holding Ltd. (ROG.S) CHF271.85 -0.05
Roche Holding Ltd. (RO.S) CHF270.60 -0.20
Abbott Laboratories (ABT.N) $81.93 -2.44
Bayer AG (BAYGn.DE) €66.59 -1.13
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.73 -0.29
AstraZeneca plc (AZN.L) 7,313.00 -11.00

收益 vs. 预测